MDAI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Spectral AI Inc (MDAI) is not a strong buy for a beginner investor with a long-term strategy at this time. While the company has secured significant funding and has promising technology, the technical indicators are bearish, financial performance shows declining revenue, and there are no strong trading signals or positive analyst trends to support an immediate buy decision. Holding off for clearer positive momentum or improved fundamentals is recommended.
The MACD is below 0 and negatively contracting, indicating bearish momentum. RSI is neutral at 60.233, providing no clear signal. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading near its resistance level (R1: 1.448). Overall, the technical indicators suggest a bearish trend.
Spectral AI secured $31.7 million in funding from BARDA to develop its DeepView System, which could aid in FDA clearance and product development. The stock saw a 35.83% increase in after-hours trading following the announcement.
Revenue dropped significantly by -53.60% YoY in Q3 2025, and gross margin declined by -4.72% YoY. The MACD and moving averages indicate bearish momentum, and there is a 30% chance the stock could decline further in the short term.
In Q3 2025, revenue dropped to $3.79M (-53.60% YoY), while net income improved to -$3.55M (+136.17% YoY). EPS increased to -0.13 (+62.50% YoY), but gross margin declined to 42.75% (-4.72% YoY). Overall, financial performance shows mixed results with declining revenue but improving net income and EPS.
No recent analyst rating or price target changes are available for MDAI.
